Sign in
HOME
FOCUS
ADDICTION
TALKING POINTS
NEWS
RESEARCH AFRICA
PEOPLE
ARCHIVE
Newsletter Archive
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, March 23, 2023
Sign in / Join
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
DEVELOPMENT – Medical Brief
HOME
FOCUS
ADDICTION
TALKING POINTS
NEWS
RESEARCH AFRICA
PEOPLE
ARCHIVE
Newsletter Archive
Home
Tags
AbbVie
Tag: AbbVie
Voluntary licensing agreements transforming HIV treatment
MBriefWSM
-
August 14, 2019
0
Glecaprevir/pibrentasvir hepatitis C treatment found safe and highly effective
MBriefWSM
-
April 24, 2019
0
NGOs want drug pricing transparency, slate govt over 'pharma friendly’ policies
MBriefWSM
-
April 17, 2019
0
Five pharmas carrying out 63% of most urgent medicines R&D projects
MBriefWSM
-
November 28, 2018
0
Key AbbVie hepatitis C drug licensed to Medicines Patent Pool
MBriefWSM
-
November 21, 2018
0
FDA approves drug for treatment of endometriosis pain
MBriefWSM
-
August 1, 2018
0
New high-sensitivity troponin test reduces heart attack risk
MBriefWSM
-
June 13, 2018
0
Interim results show affordable hepatitis C treatment to be safe
MBriefKM
-
April 18, 2018
0
Long-term data do not support raltegravir as second-line therapy
MBriefWSM
-
November 22, 2017
0
Subscribe
*
indicates required
Email Address
*
First Name
*
Last Name
*
Country
Organisation / Institution
Job Title
×
